Tissue Models & Drug Screening Conference 2015
May 5 - 6, 2015
Berlin , Germany
We invite you to the attend the 2nd Tissue Models & Drug Screening Conference, which will take place on May 5 - 6, 2015 in Berlin, Germany.
Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?
Sessions for the meeting include:
I. Human Tissue Engineered Models for Drug Development
II. Deconvolving Targets of Hits from Phenotypic Screens
III. Phenotypic Screening with Functional Analysis Including Complex Models
IV. Biomimetic in Vitro Models: Development, Structure, and Function
V. In-Vivo 3D Models for Drug Safety Testing (toxicology) and Screening
This meeting will bring together researchers from across multiple disciplines, from both industry and academia, to discuss how we can better engineer tissues for clinical delivery and develop models for drug screening.
Speakers List:
Natasa Anastasov,Christian Regenbrecht,Jeffrey Beekman,Christian Schmees,Erik Danen,Birgit Schoeberl,Jan Ehlert, Lansing Taylor and many more...
We hope to see you there!
Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?
Sessions for the meeting include:
I. Human Tissue Engineered Models for Drug Development
II. Deconvolving Targets of Hits from Phenotypic Screens
III. Phenotypic Screening with Functional Analysis Including Complex Models
IV. Biomimetic in Vitro Models: Development, Structure, and Function
V. In-Vivo 3D Models for Drug Safety Testing (toxicology) and Screening
This meeting will bring together researchers from across multiple disciplines, from both industry and academia, to discuss how we can better engineer tissues for clinical delivery and develop models for drug screening.
Speakers List:
Natasa Anastasov,Christian Regenbrecht,Jeffrey Beekman,Christian Schmees,Erik Danen,Birgit Schoeberl,Jan Ehlert, Lansing Taylor and many more...
We hope to see you there!
Organizer
626-256-6405Related events
Tissue Models & Drug Screening Conference May 5 - 6, 2015
